
About Eprogen
Eprogen is a Healthcare company based in Darien (United States) founded in 2001 by Tim Barder. It develops chromatographic methods for protein analysis and biomarker discovery in proteomics. It operates on a B2B and D2C model. Its chief executive, as recorded, is Tim Barder. Eprogen offers products and services including ProteoSep® 2D Proteomics, HPLC Columns, ProteoSep® Buffers, and Non-Porous Silica (NPS). Its focus areas include Health and Life Sciences, Analytical Chemistry, Chromatography and HPLC. Its legal entity is PROMIGEN LIFE SCIENCES, LLC. Similar companies include Nautilus Biotechnology, Somalogic and ProteinSimple; 3 of its 3 listed similar companies have raised funding.
Company details
Eprogen, operating as Promigen Life Sciences, LLC, is a bioanalytical chemistry company in Downers Grove, Illinois, USA. It focuses on developing tools for separating and analyzing complex protein systems using chromatographic and molecular biology techniques. Their activities include creating solutions for clinical proteomics and protein biomarker discovery, offering products like HPLC columns and ProteoSep systems to research labs and distributors.
- Headquarters Darien, United States
- Founders Tim Barder
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website eprogen.com
- Social Facebook
- Legal Name Promigen Life Sciences, Llc
Products & Services of Eprogen
Eprogen offers a comprehensive portfolio of products and services, including ProteoSep® 2D Proteomics, HPLC Columns, ProteoSep® Buffers, and Non-Porous Silica (NPS).
System for protein biomarker discovery using HPLC and immunoassays
Columns for high-resolution protein and peptide separations
Buffers for 2D fractionation in protein analysis
Materials for ultra-fast protein separations
People of Eprogen
1 people are tracked at Eprogen (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tim Barder | Founder, CEO | Leadership |
Complete people profiles for Eprogen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Eprogen
Eprogen has 3 listed similar companies in our database, 3 of them funded. They include Nautilus Biotechnology, Somalogic and ProteinSimple.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis |
Detailed similar companies of Eprogen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Eprogen
Websites that share an audience with Eprogen (eprogen.com).
Websites whose visitors overlap most with Eprogen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| alphalyse.com | 83% | 2.9K | View details |
Top companies in Toxicology
3 companies that operate in the same segment as Eprogen (Toxicology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | |||
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | |||
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eprogen
Eprogen was founded in 2001.
Eprogen is headquartered in Darien, United States. It is registered at Darien, Connecticut, United States.
Tim Barder is the CEO of Eprogen, as recorded in our data. They have also founded this company.
Eprogen, operating as Promigen Life Sciences, LLC, is a bioanalytical chemistry company in Downers Grove, Illinois, USA. It focuses on developing tools for separating and analyzing complex protein systems using chromatographic and molecular biology techniques. Their activities include creating solutions for clinical proteomics and protein biomarker discovery, offering products like HPLC columns and ProteoSep systems to research labs and distributors.
Eprogen's top competitors include Somalogic, Nautilus Biotechnology and ProteinSimple.
Eprogen offers ProteoSep® 2D Proteomics, HPLC Columns, ProteoSep® Buffers, and Non-Porous Silica (NPS).
Eprogen operates through Promigen Life Sciences, Llc.